Last $5.35 USD
Change Today +0.05 / 0.94%
Volume 130.9K
CCXI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward Mocarski Ph.D.

Member of Scientific Advisory Board, ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Edward Mocarski Ph.D. serves as Professor, Microbiology and Immunology of Stanford University School of Medicine where he has been on the faculty for 21 years and a tenured professor since 1989. Dr. Mocarski's research focuses on the biology and pathogenesis of herpesviruses, with particular emphasis on cytomegalovirus, an important opportunistic pathogen. His work in this area has lead to important insights into the viral gene products that control productive replication, ...

Read Full Background

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $5.35 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Herve Hoppenot Chief Executive Officer, President and Director
Incyte Corporation
--
Yasuchika Hasegawa Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.